Prostate Cancer Patients
17 clinical trials · Condition
◉ Watch Prostate Cancer Patients
| Record | Firm | Date |
|---|---|---|
| Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer (NCT07489729) | Tanta University | 2022-06-30 |
| The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole (NCT04676035) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-15 |
| Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion (NCT04664725) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-01 |
| Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736) (NCT03795207) | Institut Cancerologie de l'Ouest | 2019-03-21 |
| C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer (NCT02715583) | Abramson Cancer Center at Penn Medicine | 2016-03-01 |
| A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients (NCT03258320) | Shanghai Jiao Tong University School of Medicine | 2015-01-01 |
Track Prostate Cancer Patients automatically
Every clearance here is in the API, with alerts when new ones post.